2021-06-30FDA approves asparaginase erwinia chrysanthemi (recombinant) for leukemia and lymphomaDrug Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) · Asparagine-specific enzymeConditionsLymphoidOther hematologic neoplasm
2006-07-24FDA Approves pegaspargase (Oncaspar, Enzon Pharmaceuticals, Inc) for the first-line treatment of patients with acute lymphoblastic leukemiaDrug Oncaspar (pegaspargase) · Asparagine-specific enzymeConditionsLymphoidOther hematologic neoplasm